Search for: "Celgene Corp."
Results 41 - 60
of 81
Sort by Relevance
|
Sort by Date
27 Jul 2017, 2:42 pm
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit… The post Pharmaceutical Manufacturer Agrees to Pay $280 Million to Settle Healthcare Whistleblower Lawsuit appeared first on TZ Legal - Fraud Fighters. [read post]
27 Jul 2017, 10:37 am
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit related to allegations that it promoted cancer drugs for uses that had not been approved by the Food and Drug Administration (“FDA”). [read post]
27 Jul 2017, 10:37 am
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit related to allegations that it promoted cancer drugs for uses that had not been approved by the Food and Drug Administration (“FDA”). [read post]
14 Apr 2017, 3:02 am
Conflict Minerals: NGOs Say “Ignore Corp Fin Guidance” As noted in this Cooley blog, a number of non-governmental organizations have issued statements emphatically rejecting Corp Fin’s recently updated statement about the effect of the Court of Appeals Decision on the conflict minerals rule – and they’re asking companies to disregard the Corp Fin guidance… – Broc Romanek [read post]
10 Feb 2017, 9:46 pm
The Supreme Court decision was almost immediately cited by an Australian Patent Hearing Officer, who found that a claimed method for commercialising inventions does not constitute patentable subject matter under the Australian ‘manner of manufacture’ test: Invention Pathways Pty Ltd [2010] APO 10.The Invention Pathways decision resulted in an official change to Australian Patent Office practice whereby a claimed invention, to be patent-eligible, would not only need to involve a… [read post]
5 Jun 2016, 4:00 am
Dans Celgene Corp. c. [read post]
27 Sep 2015, 10:00 pm
Celgene Corp. had filed motions for sanctions in IPRs brought against its patents relating to Thalomid® (thalidomide) and Revlamid®... [read post]
27 Sep 2015, 10:00 pm
Celgene Corp. had filed motions for sanctions in IPRs brought against its patents relating to Thalomid® (thalidomide) and Revlamid®... [read post]
3 Aug 2015, 10:00 pm
Celgene Corp. [read post]
17 Jun 2015, 10:44 am
Celgene Corp., 985 F. [read post]
12 May 2015, 3:30 pm
Inc. 90271J184 UBS Trigger Phoenix Autocallable Optimization Securities linked to Research In Motion, Ltd. 90271J176 UBS Trigger Phoenix Autocallable Optimization Securities linked to Chesapeake Energy Corp. 90271J127 UBS Trigger Phoenix Autocallable Optimization Securities linked to Citigroup 90271H873 UBS Trigger Phoenix Autocallable Optimization Securities linked to Chesapeake Energy Corp. 90271J143 UBS Trigger Phoenix Autocallable Optimization Securities linked to Anadarko… [read post]
4 May 2014, 9:39 pm
Celgene Corp. et... [read post]
21 Apr 2014, 5:52 am
Plaintiff Andrulis Pharmaceuticals Corp. [read post]
17 Apr 2014, 8:07 am
In Andrulis Pharmaceuticals Corp. v. [read post]
12 Jun 2013, 10:16 am
She also reached the same conclusion using a purposive approach relying on the Supreme Court of Canada decision in Celgene Corp. v. [read post]
1 Apr 2012, 3:04 pm
Celgene Corp., 2010 WL 1492869, at *3 (D.N.J. [read post]
24 Jan 2012, 3:00 am
Re those net short term capital gains: Gingrich bought and sold shares in Campbell Soup in 2010 (losing 74), bought shares in Celgene Corp in 2009 and sold them in 2010 (making 2591), sold in 2010 shares in American Funds Capital bought at various times, for a 346 gain, and similarly sold shares in Nuveen High Yield fo a 1225 gain. [read post]
15 Nov 2011, 3:58 pm
Other potential acquirers could include larger pharmaceutical companies like Celgene Corp., Pfizer Inc. and Teva Pharmaceuticals, which have dabbled in stem cells without making major investments. [read post]
15 Jun 2011, 4:56 am
Lundbeck A/S (IP Whiteboard) (Patentology) Focalin XR (Dexmethylphenidate) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. et al. v. [read post]
3 Apr 2011, 10:21 pm
(“Lannett”), the self-proclaimed “oldest generic drug manufacturer” in the United States (founded in 1942), and Celgene Corp. [read post]
